MedPath

Effect of Hanzal oil on pain of diabetic neuropathy

Phase 2
Conditions
Diabetic neuropathy.
Diabetic Polyneuropathy
G 63.2*
Registration Number
IRCT201211151957N4
Lead Sponsor
Research Institute for Islamic and Complementary Medicine (Tehran University of Medical sciences)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

age 18-80 years, type 2 diabetes mellitus, painful diabetic neuropathy, pain in lower limbs, rule out other causes of neuropathy, neuropathy for more than 6 months, severity of pain more than 3 mm in visual scale of pain, written informed consent, Exclusion criteria: glycosylated hemoglobin more than 10, taking insulin, sever acute pain that requires lidocaine, active or infected wounds in lower limbs, amputation of lower limbs, pregnancy, lactation

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: before intervention, 1 month and 2 months after intervention. Method of measurement: Visual analogue scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath